Oxidative parameters in plasma
Plasma MDA levels were significantly lower in the STD group compared with the HFD group, with values of 3.16± 0.40 µmol/L and 4.31±0.33 µmol/L, respectively. Conversely, a highly significant increase was observed in the BPAHFD and TEBHFD groups, as well as in the BPA and TEB groups, compared with the HFD group. A notable difference was also observed between the TEB and TEBHFD groups, with an increase of 52% and 27%, respectively (Table 1).
Plasma-reducing power was significantly reduced in the BPAHFD, TEBHFD, BPA and TEB groups compared to the HFD group. The plasma-reducing power was significantly different between the TEB and TEBHFD groups, with values of 542.63±77.83 µmol/L versus 393.82±18.71 µmol/L.
The evaluation of protein oxidation in plasma revealed that protein thiol levels in the BPAHFD, BPA, TEBHFD and TEB groups were significantly lower than those of the HFD group.
Hepatic oxidative parameters
The HFD group exhibited elevated MDA levels compared to the STD group, with measurements of 0.0056±0.0013 µmol/g versus 0.0021±0.00026 µmol/g. The TEBHFD group showed a 40% increase in oxidised lipid levels, while the BPA and TEB groups demonstrated increases of 100% and 20% respectively, relative to the HFD group. Furthermore, pollutants and HFD exerted a significant effect on reducing power. The TEBHFD and TEB groups experienced reductions in hepatic reducing power by 47.7% and 24.47%, respectively, compared to the HFD group. A notable decrease in hepatic reducing power was observed with combined exposure to TEB and the HFD, as opposed to TEB alone (6.96±0.94 µmol/g versus 10.06±0.74 µmol/g).
Protein levels in the BPAHFD, BPA, TEBHFD and TEB groups were lower than those in the HFD group, with reductions of 5.39%, 7.55%, 25.21% and 10.33%, respectively. Additionally, in the TEBHFD group, protein concentrations of the thiol groups were lower than those of the BPAHFD group (16.64±2.81 µmol/g versus 21.05±1.33 µmol/g) (Table 2).
Histopathological study
Exposure to BPA or TEB resulted in vacuolated hepatocytes and degeneration, characterised by necrosis and sinusoidal dilation. Macrovesicular steatosis, accompanied by inflammatory cell infiltration around the vessels and an increased number of Kupffer cells, was observed in the BPAHFD and TEBHFD groups. Centrilobular hepatocyte necrosis was also noted in these groups (Fig 1).
Exposure to BPA or TEB resulted in centrilobular hepatocytic degeneration (characterized by vacuolation), necrosis, as well as sinusoidal dilation. Macrovesicular steatosis was observed in the BPAHFD and TEBHFD groups, accompanied by an increased number of Kupffer cells and inflammatory cell infiltrates. These groups also showed evidence of centrilobular hepatocyte necrosis (Fig 1).
Intestinal flora composition
The results reveal a significant increase in
Enterobacteria numbers in rats exposed to the HFD combined with TEB or BPA, compared to the HFD group (6.21±0.08 Log
10CFU/g; 5.91±0.09 Log
10 CFU/g versus 5.48±0.04 Log
10CFU/g). A significant difference was also observed between the TEB and TEBHFD groups, with a 14% increase of
Enterobacteria and between BPA and BPAHFD groups, with a 11%, respectively.
A notable disparity was detected between the TEB and TEBHFD groups with 14% rise in
Enterobacteria and between the BPA and BPAHFD groups with an 11% increase.
The staphylococcal count results indicate that TEB exposure led to a significant increase, estimated at 17% in the TEB group compared to the BPA group and 23% compared to the STD group (Fig 2).
On the other hand, a significant reduction in
Lactobacillus numbers was observed in the BPAHFD, TEBHFD and TEB groups as compared with the HFD group. Furthermore, a marked difference was detected between the BPAHFD and TEBHFD groups (5.21±0.13
versus 3.62±0.15 Log
10CFU/g) (Fig 3).
During our study, female rats were preferentially selected as they represent a particularly sensitive target to endocrine disruptors, according to Robert Barouki, Director of Research at the French National Institute for Health and Medical Research (Inserm). The majority of endocrine disruptors can imitate oestrogens and thus attach to their receptors.
The results reveal that the exposure to BPA or TEB, in conjunction with a HFD, leads to oxidative imbalance in plasma and liver tissues. Research has implicated cytochrome P450 in the bioactivation of these pollutants, particularly TEB, through increased radical production
(Dong et al., 2023). In a murine study,
Ma et al. (2023) demonstrated that TEB exposure caused lipid peroxidation, evidenced by elevated hepatic MDA levels.
Ku et al. (2021) corroborated these findings in C57BL/6 mice, highlighting TEB’s hepatotoxicity, notably through oxidative stress induction and a decrease in hepatic antioxidant defence enzymes, such as SOD, catalase and GSH. The study concludes that the accumulation of reactive oxygen species (ROS) activates pro-inflammatory cytokines (TNF-α, IL-6) and disrupts hepatic metabolism by affecting several processes: β-oxidation of fatty acids, promoting hepatic steatosis; glycolysis and gluconeogenesis, disrupting the liver’s energy balance and lipid metabolism, leading to excessive lipid accumulation
(Goudarzi et al., 2022).
Othmène et al. (2021) reported that TEB induces excessive ROS production in H9C2 cardiac cells, contributing to DNA damage, genotoxicity and apoptosis in a dose-dependent manner. This process is mediated by the activation of a caspase cascade, particularly caspases 3 and 9 and by altering the Bax/Bcl-2 ratio. The accumulation of ROS results in a reduction in mitochondrial membrane potential, thereby disrupting the cell cycle. BPA appears to operate through a similar mechanism, as observed in TM3 cells
(Zhang et al., 2023). Kamel et al. (2018) found that rats administered a high dose of BPA exhibited steatosis with inflammatory cell infiltration, sinusoid dilatation and increased Kupffer cells.
Alyasiri et al., (2025) conclude that in male rats, BPA impairs hepatic function.
Conversely, exposure of rats to TEB or BPA, either alone or in combination with HFD, alters the intestinal microbiota composition. Specifically, there was a notable increase in enterobacteria (proteobacteria) in the exposed groups compared to the control.
Liu et al. (2021) demonstrated that TEB exposure in rats disrupts the intestinal barrier, following an increase in enterobacteria and lipopolys-accharides (LPS). As noted by
Shi et al. (2019), low-grade inflammation is caused by significant translocation of LPS into the bloodstream; a phenomenon considered a key factor in the amplification of several chronic pathologies, including cardiovascular diseases and metabolic disorders.
Consistent with the findings presented, extensive research has verified the influence of TEB and BPA on the composition of the intestinal microbiota and related inflammatory processes.
Meng et al. (2022) illustrated that TEB exposure in mice led to modifications in the intestinal microbiota, characterised by structural damage and infiltration of inflammatory cells in colon tissue. Likewise,
Ma et al. (2023) found that BPA exposure disrupts the intestinal microbiota, leading to an increase in proteobacteria and LPS levels, triggering the TLR4 pathway, inducing intestinal inflammation. These outcomes align with those of
Lai et al. (2016), who observed that mice exposed to BPA and fed a high-fat diet exhibited changes in the intestinal microbiota composition. Further research by
Lopez-Moreno et al. (2024) identified a predominance of
Staphylococcus,
Escherichia and
Clostridium in the intestinal microbiota of obese children exposed to BPA. These observations are consistent with the current study, which detected
Staphylococcus and
Escherichia in the presence of BPA.